Medicare Enrolled
Dr. Nasir Asghar, M.D.
Internal Medicine · Holly Springs, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Asghar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Asghar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Asghar
Dr. Nasir Asghar is an internal medicine specialist in Holly Springs, GA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Asghar performed 1,858 Medicare services across 1,129 unique beneficiaries.
Between the years covered by Open Payments, Dr. Asghar received a total of $16,813 from 58 pharmaceutical and/or device companies across 1025 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Asghar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 20% volume in GA
$16,813 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,858
Medicare services
Top 20% in GA for internal medicine
1,129
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~109 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
346 | $55 | $211 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
346 | $94 | $272 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
216 | $0 | $8 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
195 | $10 | $67 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
143 | $129 | $279 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
122 | $1 | $20 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
69 | $29 | $39 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
64 | $75 | $195 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
60 | $3 | $13 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
60 | $0 | $12 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
55 | $9 | $82 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
48 | $16 | $44 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
34 | $63 | $245 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
27 | $41 | $123 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
18 | $282 | $414 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
18 | $28 | $37 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
15 | $14 | $55 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
11 | $35 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $121 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,813
Total received (2018-2024)
Avg $2,402/year across 7 years
Top 4% in GA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,025
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,787 (99.8%)
Other
Charitable contributions, space rental, and other categories
$14 (0.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,313
2023
$2,294
2022
$2,455
2021
$4,106
2020
$2,486
2019
$1,759
2018
$1,400
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$404
Novo Nordisk Inc
$371
Lilly USA, LLC
$201
GlaxoSmithKline, LLC.
$163
Axsome Therapeutics, Inc.
$150
AstraZeneca Pharmaceuticals LP
$146
Corcept Therapeutics
$132
Lundbeck LLC
$122
PFIZER INC.
$86
Boehringer Ingelheim Pharmaceuticals, Inc.
$83
Takeda Pharmaceuticals U.S.A., Inc.
$67
Otsuka America Pharmaceutical, Inc.
$66
Exact Sciences Corporation
$55
Antares Pharma, Inc.
$42
IDORSIA PHARMACEUTICALS US INC
$32
Amgen Inc.
$32
SANOFI-AVENTIS U.S. LLC
$26
Paratek Pharmaceuticals, Inc.
$20
Ascensia Diabetes Care Us Inc.
$20
Abbott Laboratories
$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Xeris Pharmaceuticals, Inc.
$17
Esperion Therapeutics, Inc.
$15
Currax Pharmaceuticals LLC
$14
Optos, Inc.
$13
Top 3 companies account for 42.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,702
Lilly USA, LLC
$1,346
AstraZeneca Pharmaceuticals LP
$1,247
SANOFI-AVENTIS U.S. LLC
$1,166
AbbVie Inc.
$1,038
ABBVIE INC.
$839
GlaxoSmithKline, LLC.
$757
Janssen Pharmaceuticals, Inc
$749
PFIZER INC.
$736
Takeda Pharmaceuticals U.S.A., Inc.
$642
Boehringer Ingelheim Pharmaceuticals, Inc.
$408
Antares Pharma, Inc.
$400
Axsome Therapeutics, Inc.
$366
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$356
Amgen Inc.
$349
Supernus Pharmaceuticals, Inc.
$308
Allergan, Inc.
$301
Lundbeck LLC
$266
Otsuka America Pharmaceutical, Inc.
$261
Abbott Laboratories
$258
Merck Sharp & Dohme Corporation
$153
Corcept Therapeutics
$148
Teva Pharmaceuticals USA, Inc.
$148
Bayer Healthcare Pharmaceuticals Inc.
$133
Kowa Pharmaceuticals America, Inc.
$127
Biohaven Pharmaceutical Holding Company Ltd.
$107
Daiichi Sankyo Inc.
$106
Bayer HealthCare Pharmaceuticals Inc.
$102
Biohaven Pharmaceuticals, Inc.
$102
Exact Sciences Corporation
$100
IDORSIA PHARMACEUTICALS US INC
$99
Esperion Therapeutics, Inc.
$88
Genentech USA, Inc.
$78
Merck Sharp & Dohme LLC
$72
Novartis Pharmaceuticals Corporation
$69
Eisai Inc.
$66
Allergan Inc.
$61
ARBOR PHARMACEUTICALS, INC.
$54
Medtronic, Inc.
$52
Amarin Pharma Inc.
$48
AbbVie, Inc.
$46
ITI, Inc.
$38
Arbor Pharmaceuticals, Inc.
$37
Mylan Specialty L.P.
$32
Bausch Health US, LLC
$31
Currax Pharmaceuticals LLC
$29
UPSHER-SMITH LABORATORIES LLC
$21
Paratek Pharmaceuticals, Inc.
$20
Ascensia Diabetes Care Us Inc.
$20
EISAI INC.
$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Tolmar, Inc.
$17
Xeris Pharmaceuticals, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$15
Baxter Healthcare
$14
Optos, Inc.
$13
Avion Pharmaceuticals
$12
Medicure Pharma Inc.
$11
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Amitiza · Androgel · Auvelity · BASAGLAR · BELSOMRA · BREO · BREZTRI · Balcoltra · Belviq · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · Edarbi · Edarbyclor · FARXIGA · FLECTOR · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GLASSIA · GVOKE HYPOPEN · Horizant · INJECTAFER · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · JYNARQUE · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · NEXLETOL · NFC-700 · NOCDURNA · NURTEC ODT · NUZYRA · ONZETRA XSAIL · OTREXUP · Otezla · Otrexup · Ozempic · PAXLOVID · PREMARIN · PREVNAR 13 · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Synthroid · TOSYMRA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TZIELD · Tresiba · Trintellix · UBRELVY · VENASEAL · VRAYLAR · Vascepa · Victoza · WELLBUTRIN XL · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XYOSTED · Xofluza · Xultophy 100/3.6 · Yupelri · ZEPBOUND · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in GA.
Geographic Context
Internal medicine physicians within 10 mi
885
Per 100K population
322.4
County median income
$105,442
Nearest hospital
NORTHSIDE HOSPITAL CHEROKEE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Asghar is a clinical cardiology specialist, with above-average Medicare volume (top 20% in GA), with low-engagement industry engagement in the top 4% of GA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Asghar experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Asghar performed 346 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Asghar receive payments from pharmaceutical companies?
Yes. Dr. Asghar received a total of $16,813 from 58 companies across 1,025 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Asghar's costs compare to other internal medicine physicians in Holly Springs?
Dr. Asghar's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Asghar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Holly Springs
Browse internal medicine physicians in Holly Springs ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in GA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in GA
Which GA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology